Skip to main content
Top
Published in: Medical Oncology 5/2021

01-05-2021 | Prostate Cancer | Original Paper

High KIFC1 expression is associated with poor prognosis in prostate cancer

Authors: Laurie G. Kostecka, Athen Olseen, KiChang Kang, Gonzalo Torga, Kenneth J. Pienta, Sarah R. Amend

Published in: Medical Oncology | Issue 5/2021

Login to get access

Abstract

Kinesins play important roles in the progression and development of cancer. Kinesin family member C1 (KIFC1), a minus end-directed motor protein, is a novel Kinesin involved in the clustering of excess centrosomes found in cancer cells. Recently KIFC1 has shown to play a role in the progression of many different cancers, however, the involvement of KIFC1 in the progression of prostate cancer (PCa) is still not well understood. This study investigated the expression and clinical significance of KIFC1 in PCa by utilizing multiple publicly available datasets to analyze KIFC1 expression in patient samples. High KIFC1 expression was found to be associated with high Gleason score, high tumor stage, metastatic lesions, high ploidy levels, and lower recurrence-free survival. These results reveal that high KIFC1 levels are associated with a poor prognosis for PCa patients and could act as a prognostic indicator for PCa patients as well.
Literature
34.
go back to reference Chan JY. A Clinical Overview of Centrosome Amplification in Human Cancers. Int J Biol Sci. 2011;7(8):1122–44.CrossRef Chan JY. A Clinical Overview of Centrosome Amplification in Human Cancers. Int J Biol Sci. 2011;7(8):1122–44.CrossRef
35.
go back to reference Martin SK, Kyprianou N. Chapter Three-Exploitation of the Androgen Receptor to Overcome Taxane Resistance in Advanced Prostate Cancer. In: Fisher PB, Tew KD, editors. Advances in Cancer Research, vol. 127. Cambridge: Academic Press; 2015. p. 123–58. Martin SK, Kyprianou N. Chapter Three-Exploitation of the Androgen Receptor to Overcome Taxane Resistance in Advanced Prostate Cancer. In: Fisher PB, Tew KD, editors. Advances in Cancer Research, vol. 127. Cambridge: Academic Press; 2015. p. 123–58.
Metadata
Title
High KIFC1 expression is associated with poor prognosis in prostate cancer
Authors
Laurie G. Kostecka
Athen Olseen
KiChang Kang
Gonzalo Torga
Kenneth J. Pienta
Sarah R. Amend
Publication date
01-05-2021
Publisher
Springer US
Published in
Medical Oncology / Issue 5/2021
Print ISSN: 1357-0560
Electronic ISSN: 1559-131X
DOI
https://doi.org/10.1007/s12032-021-01494-x

Other articles of this Issue 5/2021

Medical Oncology 5/2021 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.